Afya upgraded to Overweight from Neutral at JPMorgan

JPMorgan upgraded Afya (AFYA) to Overweight from Neutral with a price target of $24.50, up from $23.50. The company’s focus on medical education ?provides superior consistency and visibility,” the analyst tells investors in a research note. The firm says Afya is one of the most consistent players in the Brazilian education industry, with high visibility and never missing guidance. It views the stock as a “solid pick for the risk-averse.”